Glenmark Pharmaceuticals Ltd operates within the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Glenmark Pharmaceuticals Ltd with three other
companies in this sector in India:
Jubilant Life Sciences Limited
sales of 75.18 billion Indian Rupees [US$1.07 billion]
of which 53%
Piramal Enterprises Limited
(106.31 billion Indian Rupees [US$1.51 billion]
of which 47%
was Financial Services), and
Alkem Laboratories Ltd
(64.22 billion Indian Rupees [US$909.98 million]
During the year ended March of 2018, sales at
Glenmark Pharmaceuticals Ltd were 91.03 billion Indian Rupees (US$1.29 billion).
decrease of 0.9%
versus 2017, when the company's sales were 91.86 billion Indian Rupees.